ICOC Meeting Agenda

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE AND
THE APPLICATION REVIEW SUBCOMMITTEE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Thursday, May 29, 2014
9:00 am – 5:00 pm

Main Location
San Diego Marriott La Jolla
4240 La Jolla Village Drive
La Jolla, CA 92037

Other Locations

513 Parnassus Avenue
San Francisco, CA 

Dial in Information
Dial In: (866) 233-3841
Access Code: 327811

WebEx Link
1. Go to https://cirm.webex.com/cirm/onstage/g.php?MTID=e9cb35b652343bba81687d2e7...
2. Click "Join Now".

Audio Cast
To access the live event or archive, use this URL:
https://im.csgsystems.com/cgi-bin/confCast

Enter Conference ID# 327811
Then click Go.

[Members of the Public will be invited to provide testimony before or during consideration of each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

REPORTS & DISCUSSION ITEMS

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

4. Chairman’s Report.

5. President’s Report.

6. Finance Update.

7. Research Funding Update.

ACTION ITEMS

8. Consideration of applications for RFA 13-03A Strategic Partnership III Awards (Track A).

9. Consideration of applications for RFA 09-04: CIRM Research Leadership Awards.

10. Consideration of application for PA 14-04 Extraordinary Supplement Award (Major) from Early Translation III Award TR3 -05501

11. Consideration of appointment of new scientific members of Grants Working Group.

12. Consideration of initiating rulemaking for amendments to the Grants Administration Policy.

13. Consideration of resolution honoring Marcy Feit.

14. Consideration of resolution honoring Alan Trounson.

15. Consideration of minutes from the March 2014 ICOC Board Meeting.

16. Consideration of renewal of contract with Remcho, Johansen & Purcell, LLP.

CLOSED SESSION

17. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications for RFA 13-03A Strategic Partnership III Awards (Track A), for RFA 09-04: CIRM Research Leadership Award and for PA 14-04 Extraordinary Supplement Award (Major)  (Health & Safety Code 125290.30(f) (3) (B) and (C)).

DISCUSSION ITEMS

18. Spotlight on Disease.

19. Communications Update.

20. Public comment.  The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

© 2013 California Institute for Regenerative Medicine